Please use this identifier to cite or link to this item:
Title: Intravitreal docosahexaenoic acid in a rabbit model: preclinical safety assessment
Author: Dolz-Marco, Rosa
Gallego-Pinazo, Roberto
Pinazo-Duran, M.Dolores
Pons-Vazquez, Sheila
Domingo i Pedrol, Joan Carles
Díaz Llopis, Manuel
Keywords: Retina
Experimentació animal
Degeneració (Patologia)
Àcids grassos
Animal experimentation
Degeneration (Pathology)
Fatty acids
Issue Date: 8-May-2014
Publisher: Public Library of Science (PLoS)
Abstract: Purpose The purpose of the present study was to evaluate the retinal toxicity of a single dose of intravitreal docosahexaenoic acid (DHA) in rabbit eyes over a short-term period. Methods Sixteen New Zealand albino rabbits were selected for this pre-clinical study. Six concentrations of DHA (Brudy Laboratories, Barcelona, Spain) were prepared: 10 mg/50 µl, 5 mg/50 µl, 2'5 mg/50 µl, 50 µg/50 µl, 25 µg/50 µl, and 5 µg/50 µl. Each concentration was injected intravitreally in the right eye of two rabbits. As a control, the vehicle solution was injected in one eye of four animals. Retinal safety was studied by slit-lamp examination, and electroretinography. All the rabbits were euthanized one week after the intravitreal injection of DHA and the eyeballs were processed to morphologic and morphometric histological examination by light microscopy. At the same time aqueous and vitreous humor samples were taken to quantify the concentration of omega-3 acids by gas chromatography. Statistical analysis was performed by SPSS 21.0. Results Slit-lamp examination revealed an important inflammatory reaction on the anterior chamber of the rabbits injected with the higher concentrations of DHA (10 mg/50 µl, 5 mg/50 µl, 2'5 mg/50 µ) Lower concentrations showed no inflammation. Electroretinography and histological studies showed no significant difference between control and DHA-injected groups except for the group injected with 50 µg/50 µl. Conclusions Our results indicate that administration of intravitreal DHA is safe in the albino rabbit model up to the maximum tolerated dose of 25 µg/50 µl. Further studies should be performed in order to evaluate the effect of intravitreal injection of DHA as a treatment, alone or in combination, of different retinal diseases.
Note: Reproducció del document publicat a:
It is part of: PLoS One, 2014, vol. 9, num. 5, p. e96872-e96872
Related resource:
ISSN: 1932-6203
Appears in Collections:Articles publicats en revistes (Bioquímica i Biomedicina Molecular)

Files in This Item:
File Description SizeFormat 
650695.pdf305.26 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons